Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. Other stock markets 2026-07-06			5-day change	1st Jan Change
38.00 ^THB	+0.66%		+7.04%	+13.43%

05-15	Mega Lifesciences Public Company Limited, Q1 2026 Earnings Call, May 14, 2026
05-13	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	33,131	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	13.43%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	28,279	28,375	28,053
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	12.88%	0.34%	-1.14%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	14.3x	13.5x	12.7x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	3.11x	2.99x	2.87x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.7x	2.23x	2.01x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.23x	2.12x	2.02x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.9x	1.82x	1.71x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	8.34x	8.11x	7.56x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	9.34x	9.03x	8.42x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	13.6x	13.1x	12.7x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	7.36%	7.65%	7.87%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.774	1.876	1.993
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	4.67%	4.94%	5.24%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.662	2.823	3.001
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	66.6%	66.4%	66.4%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,877	15,612	16,401
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,390	3,497	3,713
EBIT ¹	2,305	2,681	2,904	3,370	2,585	3,028	3,143	3,332
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,320	2,460	2,617
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,852	-4,756	-5,078
Reference price ²	50.50	46.75	40.25	33.25	33.50	38.00	38.00	38.00
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	2/23/22	2/25/23	2/22/24	2/24/25	2/24/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	410.27B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%